TY - JOUR AU - Feldmann, M. AU - Brennan, F. M. AU - Maini, R. N. PY - 1996 DA - 1996// TI - Rheumatoid arthritis. JO - Cell VL - 85 UR - https://doi.org/10.1016/S0092-8674(00)81109-5 DO - 10.1016/S0092-8674(00)81109-5 ID - Feldmann1996 ER - TY - JOUR AU - Gregersen, P. K. AU - Silver, J. AU - Winchester, R. J. PY - 1987 DA - 1987// TI - The shared epitope hypothesis: an approach to understanding the molecular genetics of rheumatoid arthritis susceptibility. JO - Arthritis Rheum VL - 30 UR - https://doi.org/10.1002/art.1780301102 DO - 10.1002/art.1780301102 ID - Gregersen1987 ER - TY - JOUR AU - Holmdahl, R. AU - Andersson, E. C. AU - Andersen, C. B. AU - Svejgaard, A. AU - Fugger, L. PY - 1999 DA - 1999// TI - Transgenic mouse models of rheumatoid arthritis. JO - Immunol Rev VL - 169 UR - https://doi.org/10.1111/j.1600-065X.1999.tb01314.x DO - 10.1111/j.1600-065X.1999.tb01314.x ID - Holmdahl1999 ER - TY - JOUR AU - Snowden, N. AU - Reynolds, I. AU - Morgan, K. AU - Holt, L. PY - 1997 DA - 1997// TI - T cell responses to human type II collagen in patients with rheumatoid arthritis and healthy controls. JO - Arthritis Rheum VL - 40 UR - https://doi.org/3.0.CO;2-T DO - 3.0.CO;2-T ID - Snowden1997 ER - TY - JOUR AU - Clague, R. B. AU - Morgan, K. AU - Reynolds, I. AU - Williams, H. J. PY - 1994 DA - 1994// TI - The prevalence of serum IgG antibodies to type II collagen in American patients with rheumatoid arthritis. JO - Br J Rheumatol VL - 33 UR - https://doi.org/10.1093/rheumatology/33.4.336 DO - 10.1093/rheumatology/33.4.336 ID - Clague1994 ER - TY - JOUR AU - Barnett, M. L. AU - Kremer, J. M. AU - St. Clair, E. W. PY - 1998 DA - 1998// TI - Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. JO - Arthritis Rheum VL - 41 UR - https://doi.org/3.0.CO;2-R DO - 3.0.CO;2-R ID - Barnett1998 ER - TY - JOUR AU - Berg, L. AU - Rönnelid, J. AU - Sanjeevi, C. B. AU - Lampa, J. AU - Klareskog, L. PY - 2000 DA - 2000// TI - Interferon γ production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1*0401 and HLA-DQ8. JO - Arthritis Res VL - 2 UR - https://doi.org/10.1186/ar71 DO - 10.1186/ar71 ID - Berg2000 ER - TY - JOUR AU - Malmstrom, V. AU - Michaelsson, E. AU - Burkhardt, H. PY - 1996 DA - 1996// TI - Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. JO - Proc Natl Acad Sci USA VL - 93 UR - https://doi.org/10.1073/pnas.93.9.4480 DO - 10.1073/pnas.93.9.4480 ID - Malmstrom1996 ER - TY - JOUR AU - Kim, H. Y. AU - Kim, W. U. AU - Cho, M. L. PY - 1999 DA - 1999// TI - Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. JO - Arthritis Rheum VL - 42 UR - https://doi.org/3.0.CO;2-Z DO - 3.0.CO;2-Z ID - Kim1999 ER - TY - JOUR AU - Fugger, L. AU - Rothbard, J. AU - McDevitt, G. S. PY - 1996 DA - 1996// TI - Specificity of an HLA-DRB1*0401 restricted T cell response to type II collagen. JO - Eur J Immunol VL - 26 UR - https://doi.org/10.1002/eji.1830260431 DO - 10.1002/eji.1830260431 ID - Fugger1996 ER - TY - JOUR AU - Hammer, J. AU - Gallazzi, F. AU - Bono, E. PY - 1995 DA - 1995// TI - Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. JO - J Exp Med VL - 181 UR - https://doi.org/10.1084/jem.181.5.1847 DO - 10.1084/jem.181.5.1847 ID - Hammer1995 ER - TY - JOUR AU - Michaëlsson, E. AU - Malmström, V. AU - Reis, S. AU - Engström, Å. AU - Burkhardt, H. AU - Holm-dahl, R. PY - 1994 DA - 1994// TI - T cell recognition of carbohydrates on type II collagen. JO - J Exp Med VL - 180 UR - https://doi.org/10.1084/jem.180.2.745 DO - 10.1084/jem.180.2.745 ID - Michaëlsson1994 ER - TY - JOUR AU - Kouskoff, V. AU - Korganow, A. S. AU - Duchatelle, V. PY - 1996 DA - 1996// TI - Organ-specific disease provoked by systemic autoimmunity. JO - Cell VL - 87 UR - https://doi.org/10.1016/S0092-8674(00)81989-3 DO - 10.1016/S0092-8674(00)81989-3 ID - Kouskoff1996 ER - TY - JOUR AU - Korganow, A. S. AU - Ji, H. AU - Mangialaio, S. PY - 1999 DA - 1999// TI - From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. JO - Immunity VL - 10 UR - https://doi.org/10.1016/S1074-7613(00)80045-X DO - 10.1016/S1074-7613(00)80045-X ID - Korganow1999 ER - TY - JOUR AU - Matsumoto, I. AU - Staub, A. AU - Benoist, C. AU - Mathis, D. PY - 1999 DA - 1999// TI - Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. JO - Science VL - 286 UR - https://doi.org/10.1126/science.286.5445.1732 DO - 10.1126/science.286.5445.1732 ID - Matsumoto1999 ER - TY - JOUR AU - Holmdahl, R. PY - 1999 DA - 1999// TI - Autoimmunity: another pathway towards arthritis. JO - Curr Biol VL - 9 UR - https://doi.org/10.1016/S0960-9822(99)80328-5 DO - 10.1016/S0960-9822(99)80328-5 ID - Holmdahl1999 ER - TY - CHAP AU - Gregersen, P. K. PY - 1999 DA - 1999// BT - Genetics of rheumatoid arthritis: confronting complexity ID - Gregersen1999 ER - TY - JOUR AU - Elliott, M. J. AU - Maini, R. N. AU - Feldmann, M. PY - 1994 DA - 1994// TI - Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. JO - Lancet VL - 344 UR - https://doi.org/10.1016/S0140-6736(94)90632-7 DO - 10.1016/S0140-6736(94)90632-7 ID - Elliott1994 ER - TY - CHAP AU - Joosten, L. A. B. AU - Lubberts, E. AU - Helsen, M. M. A. PY - 1994 DA - 1994// BT - Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthrtis ID - Joosten1994 ER - TY - JOUR AU - Ault, A. PY - 1999 DA - 1999// TI - Rheumatoid arthritis drug linked to infections [news]. JO - Lancet VL - 353 UR - https://doi.org/10.1016/S0140-6736(05)75872-4 DO - 10.1016/S0140-6736(05)75872-4 ID - Ault1999 ER -